Enliven Therapeutics, Inc. SEC filings ELVN
Enliven Therapeutics, Inc. has 798 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 4 | Insider transaction | Oct 16, 2026 | Oct 14, 2026 |
| 3 | Initial insider ownership | Oct 16, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 21, 2026 | Sep 17, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Sep 17, 2026 |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 6, 2026 | Aug 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 144 | Notice of proposed sale | Jul 17, 2026 | — |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 24, 2026 | — |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 17, 2026 | — |
| 144 | Notice of proposed sale | Jun 17, 2026 | — |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 12, 2026 | Jun 11, 2026 |
| 424B5 | Prospectus supplement | Jun 12, 2026 | — |
| 424B5 | Prospectus supplement | Jun 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 144 | Notice of proposed sale | Apr 30, 2026 | — |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 17, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Jun 9, 2026 |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 144 | Notice of proposed sale | Mar 25, 2026 | — |
| 144 | Notice of proposed sale | Mar 24, 2026 | — |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 3 | Initial insider ownership | Jan 9, 2026 | Jan 7, 2026 |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 144 | Notice of proposed sale | Dec 17, 2025 | — |
| S-8 | Employee stock plan registration | Dec 16, 2025 | — |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 12, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 19, 2025 | — |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K/A |
Amended current report
Results of operations
|
Nov 13, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 17, 2025 |
| 144 | Notice of proposed sale | Oct 20, 2025 | — |
| 144 | Notice of proposed sale | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 9, 2025 | Oct 7, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 4 | Insider transaction | Sep 25, 2025 | Sep 23, 2025 |
| 4 | Insider transaction | Sep 25, 2025 | Sep 23, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 19, 2025 | Sep 17, 2025 |
| 144 | Notice of proposed sale | Sep 19, 2025 | — |
| 144 | Notice of proposed sale | Sep 17, 2025 | — |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 4/A | Filing | Aug 21, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 21, 2025 | Aug 19, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 18, 2025 |
| 144 | Notice of proposed sale | Aug 19, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 7, 2025 |
| 144 | Notice of proposed sale | Aug 7, 2025 | — |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| 144 | Notice of proposed sale | Jul 28, 2025 | — |
| 4 | Insider transaction | Jul 23, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 17, 2025 |
| 144 | Notice of proposed sale | Jul 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 144 | Notice of proposed sale | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 14, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 9, 2025 | Jul 7, 2025 |
| 144 | Notice of proposed sale | Jul 7, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 144 | Notice of proposed sale | Jun 27, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 144 | Notice of proposed sale | Jun 20, 2025 | — |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 17, 2025 | — |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 144 | Notice of proposed sale | Jun 17, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 16, 2025 | Jun 13, 2025 |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| 144 | Notice of proposed sale | Jun 13, 2025 | — |
| S-3MEF | Filing | Jun 13, 2025 | — |
| 424B5 | Prospectus supplement | Jun 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 4 | Insider transaction | May 21, 2025 | May 19, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlingame, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1672619
- Former names
- IMARA Inc. (until Feb 23, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.